SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.305-3.0%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steve Smith who wrote (102)8/15/1997 10:21:00 PM
From: Chi-X   of 3578
 
GERN makes the Motley Fool on Evening news read by thousands!

fool.com

<<"Biopharmaceutical" company GERON CORP. (Nasdaq: GERN) exploded $7 1/2 higher to $14 after announcing late yesterday that it had successfully cloned the gene for the human telomerase catalytic protein. The absence of this protein in later years of life means death for cells -- being able to supply the protein will mean just the opposite. The protein may also have a far-reaching impact on cancer therapies, as it addresses the uncontrolled division of cells, which is how cancer gets out of control and is the reason why blunt-force chemotherapy is used to treat cancer. Could this lead to the fountain of youth? Who knows, but we bet that a good many of this weekend's newscasts throughout the U.S. will feature this story.>>


Cheers,
Chi-X has Spoken!


CEO
Chi International
members.aol.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext